| Tag | Content |
|---|
EnhancerAtlas ID | HS116-14289 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr17:8368250-8369390 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr17:8369176-8369197 | CCCTCCCCCTCTTGCTGCTTC | - | 7.07 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_01584 | chr17:8365072-8369454 | Aorta |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I008464 | chr17 | 8368277 | 8369183 |
|
Enhancer Sequence | TTGAGGAGCC ATCTCCTAGT TGCTGCTTTT GTACACCCCC GTGGCCCAGG TGCCAGATTC 60
TTCTTGGCAT CCAATGGTGC TCCCTTTCTG CTGGGTTCCG GGCACTGTCT GCAGTACAGG 120
TTTAGGGGCT TGCCTGCCAC TGTGATGTGT GAGGCCAGGA ATCTGAGGTT CACACGTGCT 180
GAGAGCTGCA GGCATTTGTG GGGCCTGCCT GGTTGTCCCT GAGGTTTCTA GGAGAAGCAG 240
GTGTCAGGGA CTCTGGGACT AGCCAGACAG ATGGAGCCTA TTATATGAGG GCTACCGTGG 300
CAAATAGGAT ATGGCCTTGG CCCCAGAAGA GGCACAGGCC TGTGACCTTG GGAGAGTGGG 360
AAGGATGATT TCAAACTTGC AAATGTGTTG AAGCTCAAAA ATCAGACCTA ACCCAGTGAG 420
GAAAGAGACA ATCTGGCTGT TTGTCGTCGA AGTAGGACAG TGTGCAACAG GGAGAAATGA 480
CATTTGTCAG AGCCTTTCTC CTGGGGCTCT TGGTCTCTGT ATGCGTGGTT GGAATTTAAA 540
CTCCACATAT GTACTCTGAG TTTAGTTTCT TTAGACATGA ACTTTGTTTC TTCCAAGTAG 600
GCAGGGACTA TTTGTCAAGT CTCTGCATGC CTGTTTGTCT GTGAGGTTAT CCTCACCCCG 660
TCAGTGTACG AAACAGCTGT CTCTGCAGGG AGTGTGTGTC GGCATTTTTT TTTTTTAAGG 720
AGAACCTCTC TCCATGAGTC TGTATTTAGC TCCCTGGAGC CGTCTGATGA GTAGGTGGGG 780
GCAGTAGTGG GCAGGTGTGG TGCAGTGTGG CCCCTTGTCG TAGTTGGCTT TATCTCCCAA 840
ATTGCTAGTG GGACAAATTT TCCTAGGAAG CGTTTCAAGG TGGAAAGGCT GAAGTGGCTC 900
CTGAGAGAGG TTCCAGGCTG CACACTCCCT CCCCCTCTTG CTGCTTCCTG TGGCTGCGCT 960
GCATGGTGCG TGAGGGGGAT GCTTGGGGGG CTCCCTGCAT CGCTGGGCTC TGGGTGCGTG 1020
ATGGGGACGC TGGGGGGCTC CCTGTGTCGC TGGGCTCCGG GTGCTGGGTC CTGGCTGCAG 1080
GCTATTGGGT TGGGCTGGGC TGTCTGCACA CGAGTCTGCG TTGAAAAGCC TACTCATCTG 1140
|
